Navigation Links
Modigene Announces Successful Completion of Pharmacokinetic &,Pharmacodynamic Pre-Clinical Experiments for Proprietary,Long-Acting Human Growth Hormone, Long-acting Interferon Beta and,Long-acting Erythropoietin

VIENNA, Va., June 20, 2007 /PRNewswire/ -- Modigene Inc., a Nevada corporation today announced the successful completion of pharmacokinetic and pharmacodynamic pre-clinical experiments for long-acting human growth hormone, long-acting interferon beta and long-acting erythropoietin.

Modigene's pharmacodynamic and pharmacokinetic pre-clinical experiments demonstrated superb durability of the long-acting proteins, indicating a potential administration protocol in patients of once per week or up to once every four weeks, pending the specific protein and disease indication. The models were conducted using the industry standard animal models and methods as well as comparative studies to the commercially available versions. Human growth hormone is used to treat growth failure in children and adults, is injected 3-7 times per week, and has an existing estimated market size of $2.2 billion; while interferon beta is prescribed for the treatment of multiple sclerosis, is injected 1-3 times per week, and has an existing estimated market size of $3.8 billion. Neither of these markets currently have a commercial long-acting version available.

In addition, Modigene's long-acting erythropoietin has demonstrated, in a pre-clinical animal model comparative study, increased durability and biological effect over Amgen Inc.'s Aranesp(R), a long-acting erythropoietin with reported sales of $4.1 billion in 2006, out of a total estimated EPO market size of $11.7 billion. Erythropoietin is prescribed for the treatment of anemia.

"We are very excited about Modigene's pre-clinical work to date," said Dr. Phillip Frost, Vice Chairman of Teva Pharmaceutical Industries, and Modigene's largest shareholder and board member. "With four CTP-modified proteins demonstrating to date exceptional results, including Schering-Plough/Organon's FSH-CTP now in Phase III clinical trial, and Modigene's human growth hormone, interferon
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

Post Your Comments:
(Date:11/20/2009)...., Nov. 20 The Departme...hots to members of priority groups that did not ha...f 18 clinics are being held statewide on Nov. 20-2... Hours on Saturday, Nov. 21, will be 8 a.m. to 2 p...rom 2 p.m. to 8 p.m. ,, Individuals in the rec...
(Date:11/20/2009)...ov. 20 ,, Reportlinker.com anno...le in its catalogue. ,, Global Markets for Bre...linker.com/p0164741/Global-Markets-for-Breast-Biop..._medium=pr&utm_campaign=prnewswire ,, The... the spring loaded core needle market and vacuum a...
(Date:11/20/2009)... 20 Cyberonics, Inc. (Na...ident and Chief Executive Officer, and Greg Browne...t Annual Piper Jaffray Health Care Conference in N... EST. The conference session and webcast will be ... Piper Jaffray will host a webcast of the present...
Breaking Medicine Technology:Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Press Ganey Announces Opening of Boston Office 50837 1Press Ganey Announces Opening of Boston Office 50837 2Cancer Roadmaps Chooses Tableau Software for Consumer Access to Online Interactive Dashboards for Cancer Patients 50834 1Cancer Roadmaps Chooses Tableau Software for Consumer Access to Online Interactive Dashboards for Cancer Patients 50834 2Cancer Roadmaps Chooses Tableau Software for Consumer Access to Online Interactive Dashboards for Cancer Patients 50834 3Nitrogen research shows how some plants invade take over others 9126 1Nitrogen research shows how some plants invade take over others 9126 2
...icromet, Inc.,(Nasdaq: MITI ), a biopharmaceutic...s for the treatment of cancer, inflammation and au...s anticipated for the year 2009. , Micromet in...elopment,programs at the following events: , -...cal BiTE antibodies at,the American Association fo...
...3 Warner Chilcott Limited (Nasdaq: WCRX ) annou...Pharma International Pty. Ltd. ("Mayne"), a subsid... each of Mutual Pharmaceutical Company, Inc. ("Mut...pax Laboratories, Inc. ("Impax") in the District ...ent of Mayne,s U.S. Patent No. 6,958,161 (the ",16...
Other Medicine Technology:Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3
(Date:11/20/2009)... Mass., Nov. 20 Following a recall...ny removed from sale Shedd,s Country Crock ® ...,s Country Crock ® Side Dishes DELUXE Four Ch... ,, The following code dates and UPCs are affec...es DELUXE Cheddar Broccoli Rice 21 oz, UPC 0274002...
(Date:11/20/2009)...LOUIS, Nov. 20 Centene...t will present at the Bank of America Merrill Lync... 2009, at the Crowne Plaza Hotel Times Square in N..., December 2nd at 8:30 a.m. Eastern Time. Investor...audio webcast of Centene,s presentation at: http:...
(Date:11/20/2009)...W YORK, Nov. 20 SIRIUS X... will broadcast Doctor Radio Reports: What Ever...th special hosted by veteran journalist Perri Pelt...rnh/20080819/NYTU044LOGO ) ,, Doctor Radio R...grams will air November 21 live at 10:00 am ET ...
(Date:11/20/2009)...gton) November 20, 2009Emergency medical service (...mated 350,000 cardiac arrests each year. Only 5 t...est survive. Better quality cardiopulmonary resus...rs may be associated with better patient outcome. ...e largest clinical research network to study preho...
(Date:11/20/2009)...ds more severe cases than with seasonal flu , ...ian researchers are reporting that children with a...1N1 flu than seasonal flu. , "Asthma has been i...on with pandemic H1N1 influenza, present in 21 per...r. Upton Allen and fellow researchers from the Hos...
Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...llution than motorcycles, according to the results... for Materials Testing and Research’s Martin Weile...which revealed that the hydrocarbons emission of m...d by motorcycles were also disproportionately high...
...an increase in the number of cases reported with r...h disease // . The Department of Primary Indu...the property in Wentworth and found that the cause...of New South Wales said that than are more than 70...
... passed by the Food and Drug Administration (FDA) ...in the food // had to be mentioned in the label of...e under common food allergens are milk, eggs, fish...f death in US. The list of ingredients accounted t...
...ted by researchers from the Georgetown University ... had received their much-deserved respect. An exam... forms demonstrated that dwarfism was not consider...in many households. The hot, dry climate and sophi...
... expected to be conducted in China for the first t...l concerned had suffered extensive burn injuries /...her own aunt who used vitriol liquor in an act of ...jing Military Command’s research team led by Hong ...
...tion (FDA) has imposed strict and new guidelines t...t in candies. Lead is a very high toxic // metal w...ill effects of these lead the FDA as imposed that ...children’s and is safe for children’s to have thes...
Other Medicine News:Health News:Respecting Dwarfs- A Lesson To Be Learnt From Ancient Egyptians 2
Jet Wire Twister
Osteophyte Periosteal Elevator
Large Bone Curettes
Maltz Rasp
Medicine Products: